Experimental Drug Eases Autistic Behaviors in Mice

<p>WEDNESDAY, Apr 25 (HealthDay News) An initial drug
reduced dual signature characteristics of autism repetitive behavior and
abnormal social interactions in laboratory mice, new research
finds.
The drug, GRN-529, targets glutamate, a vital neurotransmitter found
throughout a mind thats concerned with activating neurons, or brain
cells. Researchers trust a devalue works by a specific glutamate
receptor (mGluR5) and decreases glutamate activity.
Researchers bred mice to have a hallmarks of autism including
unusual amicable interactions, marred communication and repetitive
self-grooming and injected them with GRN-529.
Almost immediately, a mice showed fewer repeated behaviors and more
normal amicable interactions, nonetheless their communication was still not
typical.
These commentary offer support that investigate focused on developing
medicines for core symptoms of autism are gaining momentum, pronounced study
co-author Robert Ring, clamp boss for translational investigate ...